{
  "id": 1021048,
  "title": "The science behind Simtriyo, the first ADHD medication to target three major neurotransmitters",
  "url": "https://urgent.news/2026/08/15/the-science-behind-simtriyo-the-first-adhd-medication-to-target-three",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-15T11:00:52.000Z",
  "source": {
    "name": "PsyPost",
    "slug": "psypost",
    "url": "https://www.psypost.org/the-science-behind-simtriyo-the-first-adhd-medication-to-target-three-major-neurotransmitters/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Centanafadine represents a new class of ADHD medication that uniquely targets three major brain chemicals. By preventing the reuptake of dopamine, noradrenaline, and serotonin, the daily tablet reduces hyperactivity while potentially offering broader mood-regulating benefits.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "The Conversation AU",
        "title": "A new ADHD drug targets three brain chemicals instead of two. Here’s what that means",
        "url": "https://urgent.news/2026/08/13/a-new-adhd-drug-targets-three-brain-chemicals-instead-of-two-heres",
        "published": "2026-08-13T03:52:03.000Z"
      },
      {
        "outlet": "Medical Xpress",
        "title": "A new ADHD drug targets three brain chemicals instead of two. Here's what that means",
        "url": "https://urgent.news/2026/08/13/a-new-adhd-drug-targets-three-brain-chemicals-instead-of-two-heres-771884",
        "published": "2026-08-13T12:40:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}